Zai Lab Limited ADR’s recent filing unveils that its Officer Edmondson Frazor Titus III acquired Company’s shares for reported $0.28 million on Nov 21 ’25. In the deal valued at $19.78 per share,14,328 shares were bought.
Then, Chen Yajing sold 240 shares, generating $6,439 in total proceeds. Upon selling the shares at $26.83, the Chief Financial Officer now owns 17,444 shares.
Before that, Chen Yajing bought 240 shares. Zai Lab Limited ADR shares valued at $6,439 were divested by the Officer at a price of $26.83 per share.
A number of analysts have revised their coverage, including Scotiabank’s analysts, who began to cover the stock in early March with a ‘”a Sector outperform”‘ rating. BofA Securities also remained covering ZLAB and has decreased its forecast on March 03, 2025 with a “Neutral” recommendation from previously “Buy” rating. Morgan Stanley started covering the stock on December 14, 2023. It rated ZLAB as “an Overweight”.
Price Performance Review of ZLAB
On Monday, Zai Lab Limited ADR [NASDAQ:ZLAB] saw its stock fall -0.45% to $19.93. Over the last five days, the stock has lost -4.73%. Zai Lab Limited ADR shares have fallen nearly -24.02% since the year began. Nevertheless, the stocks have fallen -23.90% over the past one year. While a 52-week high of $44.34 was reached on 06/12/25, a 52-week low of $19.51 was recorded on 11/21/25.
Levels Of Support And Resistance For ZLAB Stock
The 24-hour chart illustrates a support level at 19.72, which if violated will result in even more drops to 19.52. On the upside, there is a resistance level at 20.21. A further resistance level may holdings at 20.50.
How much short interest is there in Zai Lab Limited ADR?
A steep rise in short interest was recorded in Zai Lab Limited ADR stocks on 2025-10-31, growing by 0.12 million shares to a total of 5.02 million shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 4.9 million shares. There was a rise of 2.46%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 10, 2023 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating along with a $70 price target.
